Endexx Corp
OTC:EDXC

Watchlist Manager
Endexx Corp Logo
Endexx Corp
OTC:EDXC
Watchlist
Price: 0.0036 USD -28%
Market Cap: 1.8m USD

EV/EBITDA
Enterprise Value to EBITDA

-1.1
Current
-4.3
Median
12.6
Industry
Higher than median
Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
-1.1
=
Enterprise Value
3.5m USD
/
EBITDA
-3.1m USD
EBITDA Growth EV/EBITDA to Growth
US
Endexx Corp
OTC:EDXC
Average EV/EBITDA: 433.2
Negative Multiple: -1.1
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
33.1
30%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
12.3
7%
1.8
DK
Novo Nordisk A/S
CSE:NOVO B
13.4
13%
1
CH
Roche Holding AG
SIX:ROG
9.4
5%
1.9
CH
Novartis AG
SIX:NOVN
10.1
5%
2
UK
AstraZeneca PLC
LSE:AZN
130.7
10%
13.1
US
Merck & Co Inc
NYSE:MRK
8.3
8%
1
IE
E
Endo International PLC
LSE:0Y5F
261.3
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.3
2%
3.6

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
-0.7
2-Years Forward
EV/EBITDA
N/A
3-Years Forward
EV/EBITDA
N/A